MedTrace Logo

What Treatment for Patients With Phlebitis or Pulmonary Embolism ?

NCT03889457 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2019-03-26

No results posted yet for this study

Summary

The objective of the "anticoagchoice" study is to analyze the preferences of people suffering from phlebitis, in terms of anticoagulant, to improve adherence to these treatments, to adapt the medical prescriptions.

Conditions

  • Venous Thrombosis or Pulmonary Embolism

Interventions

OTHER

anticoagulation choice

Type of anticoagulant chosen by the patient (oral or injectable).

Sponsors & Collaborators

  • SFMV (French Society of Vascular Medicine)

    collaborator UNKNOWN

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Guillaume Mahe · Rennes University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-12
Primary Completion
2021-02-12
Completion
2021-02-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03889457 on ClinicalTrials.gov